6505–Topiramate Tablets

Amendment 0002 Published extension of solicitation response deadline from 5/13/2025 to 5/19/2025 2:30PM CT for Topiramate Tablets. Offerors are required to sign this amendment and return one copy.

Solicitation Description

Amendment 0002 Published extension of solicitation response deadline from 5/13/2025 to 5/19/2025 2:30PM CT for Topiramate Tablets. Offerors are required to sign this amendment and return one copy.

Solicitation in a Nutshell

Item

Details

Agency Department of Veterans Affairs
Solicitation Number 36E79725R0031
Status Post-RFP
Solicitation Date 03/26/2025
Award Date N/A
Contract Ceiling Value N/A
Competition Type N/A
Type of Award N/A
Primary Requirement Drugs and Biologicals
Duration N/A
Contract Type N/A
No. of Expected Awards N/A
NAICS Code(s): 325412
Pharmaceutical Preparation Manufacturing
Size Standard: 1300 Employees
Place of Performance:
  • United States
Opportunity Website: https://sam.gov/opp/b1f9bf4bc0cd4786aac37e76f08381a4/view

6505–Topiramate Tablets Background

N/A

6505–Topiramate Tablets Requirements

N/A

How can GDIC Help?

As a consulting firm that specializes in helping companies prepare winning proposals for government contracts, GDIC can provide a wide range of services to help offerors prepare their C2E proposal, including capture management, proposal writing, proposal management, and proposal review. GDIC can also provide training and support to help offerors understand the technical and administrative requirements outlined in the solicitation, and can provide guidance on how to structure the proposal to maximize its chances of success.

Our business development and proposal professionals have several decades of experience and expertise in construction proposals and contracts for government. By working with GDIC, offerors can increase their chances of winning the C2E contract and can position themselves for long-term success in the federal marketplace.